Literature DB >> 20824398

Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction.

Shigehiko Katoh1, Tetsuro Shishido, Daisuke Kutsuzawa, Takanori Arimoto, Shunsuke Netsu, Akira Funayama, Mitsunori Ishino, Takeshi Niizeki, Satoshi Nishiyama, Hiroki Takahashi, Takehiko Miyashita, Takuya Miyamoto, Joji Nitobe, Tetsu Watanabe, Isao Kubota.   

Abstract

OBJECTIVE: Iodine-123-metaiodobenzylguanidine ((123)I-MIBG) has been used to assess the function of the cardiac sympathetic nervous system in patients with chronic heart failure (HF). The usefulness of (123)I-MIBG imaging for evaluating patients with heart failure with preserved ejection fraction (HFPEF) has not been established.
METHODS: We performed (123)I-MIBG scintigraphy and echocardiography and measured the plasma brain natriuretic peptide (BNP) levels of 117 consecutive HF patients (64 men, mean age 66 ± 14 years) with a left ventricular ejection fraction (LVEF) of ≥50% who were admitted to our hospital. Patients were divided into 2 groups according to the New York Heart Association (NYHA) functional class.
RESULTS: The (123)I-MIBG delayed heart-to-mediastinum (H/M) ratio was significantly lower, and the washout rate (WR) was higher in patients with HFPEF with advanced NYHA functional class (NYHA functional class I and II vs. III: 1.90 ± 0.34 vs. 1.49 ± 0.32, p < 0.0001; 25.9 ± 13.4 vs. 46.9 ± 16.3%, p < 0.0001, respectively). On the other hand, the (123)I-MIBG WR was not correlated with LVEF and had a weak correlation with plasma BNP levels (R = 0.207, p = 0.0346). Moreover, patients with a high (123)I-MIBG WR showed a poor clinical outcome (p = 0.0033).
CONCLUSIONS: (123)I-MIBG imaging provides independent prognostic information in patients with HFPEF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824398     DOI: 10.1007/s12149-010-0409-3

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  16 in total

1.  Mechanisms of Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.

Authors:  Satyam Sarma; Douglas Stoller; Joseph Hendrix; Erin Howden; Justin Lawley; Sheryl Livingston; Beverley Adams-Huet; Courtney Holmes; David S Goldstein; Benjamin D Levine
Journal:  Circ Heart Fail       Date:  2020-03-13       Impact factor: 8.790

Review 2.  Newer applications of nuclear cardiology in systolic heart failure: detecting coronary artery disease and guiding device therapy.

Authors:  Mati Friehling; Prem Soman
Journal:  Curr Heart Fail Rep       Date:  2011-06

3.  Imaging of the Cardiac Sympathetic Nervous System Has Potential Value in the Evaluation of Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Nabil E Boutagy; Albert J Sinusas
Journal:  J Nucl Med       Date:  2017-02-23       Impact factor: 10.057

Review 4.  Multi-modality imaging: Bird's eye view from the 2016 American Heart Association Scientific Sessions.

Authors:  Wael A AlJaroudi; Steven G Lloyd; Farooq A Chaudhry; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-02-15       Impact factor: 5.952

5.  Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome.

Authors:  Shinpei Kadowaki; Tetsuro Shishido; Yuki Honda; Taro Narumi; Yoichiro Otaki; Daisuke Kinoshita; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Takuya Miyamoto; Tetsu Watanabe; Isao Kubota
Journal:  Heart Vessels       Date:  2015-01-24       Impact factor: 2.037

Review 6.  Integrating the myocardial matrix into heart failure recognition and management.

Authors:  Francis G Spinale; Michael R Zile
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

7.  Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease.

Authors:  Letizia Spinelli; Teresa Pellegrino; Antonio Pisani; Caterina Anna Giudice; Eleonora Riccio; Massimo Imbriaco; Marco Salvatore; Bruno Trimarco; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-07       Impact factor: 9.236

8.  Direct Assessment of Muscle Sympathetic Nerve Activity During Exercise in Heart Failure With Preserved Ejection Fraction: A Case Report.

Authors:  Kanokwan Bunsawat; Stephen M Ratchford; Jeremy K Alpenglow; John J Ryan; Russell S Richardson; D Walter Wray
Journal:  J Card Fail       Date:  2020-11-06       Impact factor: 5.712

9.  Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study.

Authors:  Taro Narumi; Tetsuro Shishido; Nobuyuki Kiribayashi; Shinpei Kadowaki; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Takehiko Miyashita; Takuya Miyamoto; Tetsu Watanabe; Yoko Shibata; Tsuneo Konta; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  Exp Diabetes Res       Date:  2012-10-10

10.  Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction.

Authors:  Satoshi Suzuki; Tetsuro Shishido; Akira Funayama; Shunsuke Netsu; Mitsunori Ishino; Tatsuro Kitahara; Toshiki Sasaki; Shigehiko Katoh; Yoichiro Otaki; Tetsu Watanabe; Yoko Shibata; Alberto Mantovani; Yasuchika Takeishi; Isao Kubota
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.